pancreaticobiliary disease
Conditions
Interventions
ice water group ERCP will be performed, and at the end of the procedure, ice water will be injected on the duodenal papilla. A total of 250 ml is injected five times with a 50 ml syringe. The water
Sponsors
Kitano Hospital, Tazuke Kofukai Medical Research Institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The inclusion criteria are applied to patients who were scheduled to undergo an ERCP.
Exclusion criteria
Exclusion criteria: (1) evaluated 4 levels according to the Eastern Cooperative Oncology Group Performance Status (2) age younger than 20 years (3) not native papilla (4) those cases that were expected to have duodenal papilla that were inaccessible by endoscopy (5) case of post gastrectomy (excluding B-I reconstruction) (6)presence of acute pancreatitis (7) presence of chronic pancreatitis (8) presence of pancreatic head cancer with occlusion of the main pancreatic duct (9)inability to provide written informed consent (10)subjects deemed inappropriate for the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PEP incidence | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Incidence of PEP in patients with difficult bile duct or pancreatic duct intubation, (2) Incidence of PEP by various ERCP procedures (bile duct purpose, pancreatic duct purpose, EST, EPBD, biopsy, IDUS, bile duct stenting, etc.), (3) Incidence of PEP by presence or absence of pancreatic duct cannulation or pancreatography, (4) Incidence of PEP by cannulation time, ( (5) Severity of PEP, (6) Incidence of PEP by high risk factors for PEP, (7) Incidence of other complications | — |
Countries
Japan
Contacts
Public ContactShunjiro Azuma
Kitano Hospital, Tazuke Kofukai Medical Research Institute Department of Gastroenterology and Hepatology
Outcome results
None listed